Shalby Medtech CEO Deepak Anand resigns effective Sept 4, 2026
SHALBY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.3 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mr Deepak Anand resigned as CEO of Shalby Medtech Limited, a wholly-owned subsidiary of Shalby Limited, effective close of business on September 4, 2026. Reason cited is personal as he is moving abroad. No other material reasons were given. He will assist with an orderly handover till his last working day.
Subsidiary-level management change; limited direct impact on listed Shalby Limited. Watch for a successor announcement at Shalby Medtech.